Trials / Recruiting
RecruitingNCT06144164
A Study of a Comprehensive Prevention Program to Reduce Lymphedema After Axillary Lymph Node Dissection in People With Breast Cancer
A Prospective Cohort Study of Patients Undergoing ALND for Treatment of Breast Cancer: The Efficacy of a Comprehensive Prevention Program in Decreasing the Incidence of Lymphedema and Improving Quality of Life
- Status
- Recruiting
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 285 (estimated)
- Sponsor
- Memorial Sloan Kettering Cancer Center · Academic / Other
- Sex
- Female
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study to test whether a comprehensive program may help the lymph fluid to drain out of the arm and prevent lymphedema in participants with breast cancer.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Immediate Lymphatic Reconstruction | Immediate Lymphatic Reconstruction will happen at the time of Axillary Lymph Node Dissection |
| DIAGNOSTIC_TEST | Volumetric arm measurements | Volumetric arm measurements will occur at each in-person postoperative visit time points. |
| OTHER | Lymphatic massage | Participants will begin self-directed lymphatic massage 24 to 48 h after surgery and will continue to do lymphatic massage 3 times a week for 3 months after surgery or until 3 months after any adjuvant treatments (chemotherapy, radiation, etc.) are completed |
| OTHER | Range of motion exercises | Participants will begin self-directed lymphatic massage 24 to 48 h after surgery and will continue to do lymphatic massage 3 times a week for 3 months after surgery or until 3 months after any adjuvant treatments (chemotherapy, radiation, etc.) are completed |
| OTHER | Compression garment use | Participants will use compression garments 24 to 48 h after surgery and will continue daily use for at least 8 h a day for 3 months or until 3 months after any adjuvant treatments are completed |
Timeline
- Start date
- 2023-11-16
- Primary completion
- 2030-03-16
- Completion
- 2030-03-16
- First posted
- 2023-11-22
- Last updated
- 2025-11-10
Locations
7 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT06144164. Inclusion in this directory is not an endorsement.